OR WAIT null SECS
April 22, 2025
Article
The model could allow cardiologists to inform and prepare patients before symptoms of hypertrophic cardiomyopathy make themselves known.
April 14, 2025
Video
Bhatt discusses his expectations for the future of cardiology in 2025, including GLP-1-RAs and the push towards combination therapy.
April 11, 2025
Ruff discusses his expectations for cardiology for the rest of 2025, including new research into GLP-1 receptor agonists.
April 10, 2025
Le discusses his anticipation for the results of upcoming cardiology trials in 2025, including HORIZON and Target-D.
April 08, 2025
Our Q1 2025 recap for cardiology spotlights 6 regulatory updates, 5 key trial announcements, and top expert perspectives in cardiac care.
April 01, 2025
Ahmad Masri, MD, MS, discusses how new options change the historic approach to the treatment of newly diagnosed ATTR-CM.
Daniel Judge, MD, discusses data from a prespecified analysis of ATTRibute-CM examining the effects of acoramidis with and without concomitant tafamidis use.
Ahmad Masri, MD, MS, discusses data detailing the effects of aficamten in oHCM from the FOREST-HCM OLE study at ACC.25.
March 31, 2025
Jose Lopez, MD, discusses findings and perspective into racial and ethnic differences in DbCM from the ARISE-HF trial.
March 28, 2025
In this video, the last in a 4-part series, panelists discuss how ongoing research and efforts could shape the future of ATTR-CM management.
